The Board will consider, approve and take on record the following matters:
- Unaudited Standalone & Consolidated Financial Results together with its Limited Review Report for the Quarter ended on June 30, 2026.
- Consideration and evaluation of raising funds by way of issue of equity shares or any other eligible securities/instruments, including fully or partly convertible debentures, or by way of a composite issue of non-convertible debentures and warrants entitling the warrant holder(s) to apply for equity shares or any other eligible securities. The fundraising may occur through one or more permissible modes including qualified institutions placement, private placement, further public issue of equity/debt securities, preferential issue, rights issue or any other mode and/or combination thereof, subject to statutory, regulatory and other approvals including approval of the members of the Company.
- Any other matter with the permission of the Chairperson.
Pursuant to the earlier intimation of closure of the trading window (ref no. JSL/HO/CS/GEN/26-27/23 dated June 24, 2026), the Trading Window for dealing in the securities of the Company continues to remain closed for all Officers and Designated Persons/Insiders with effect from July 1, 2026 until 48 hours after declaration of Unaudited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2026.
The disclosure is signed by Sonali K. Gaikwad, Company Secretary (FCS 13908) on July 30, 2026.